Local 12 highlights Pancreatic Cancer Awareness Month

Pancreatic cancer diagnoses are increasing more rapidly than any other cancer type while remaining one of the most deadly cancers. 

The American Cancer Society estimates approximately 64,000 Americans will be diagnosed with pancreatic cancer this year, and approximately 50,500 people in the U.S. will die of pancreatic cancer in 2023. While currently the third-leading cause of cancer death in the United States, pancreatic cancer is expected to become the second-leading cause of cancer death by 2030, highlighting the need for new and innovative treatments. 

During Pancreatic Cancer Awareness Month in November, the University of Cincinnati's Andrew Waters, PhD, joined Local 12's What's Happening in Health program to discuss the state of pancreatic cancer research.

"Now what I'm working on, there's been milestone advancements, and we have these drugs that are going through clinical trials here in the Cincinnati area," said Waters, University of Cincinnati Cancer Center researcher and assistant professor in the UC College of Medicine’s Department of Surgery, Division of Surgical Oncology and Department of Cancer Biology. "And what I'm trying to understand is how these cells when treated with this drug kind of adapt and develop resistance to the drug. Because we know it's going to be combination therapies that are necessary to really extend the lives of pancreatic cancer patients and the efficacy of this new class of drugs in the clinic."

Waters was joined by volunteers from the Pancreatic Cancer Action Network, who raise funds to support research, including at the Cancer Center.

"Finding this disease early, if possible, will really help increase the odds. Your chance of survival goes up from 12% for five-year survival to 33% if you can find the disease early,” said Sherry Holcomb, mission chair of the local chapter of the Pancreatic Cancer Action Network.

Watch or read the Local 12 story.

Read more about Waters' research.

Featured photo at top: Researchers Krushna Patra, Andrew Waters and Patrick Krause review data. Photo/Andrew Higley/UC Marketing + Brand.

Related Stories

9964 Results
1

President picks exceptional talent

April 28, 2021

The University of Cincinnati 2021 Presidential Leadership Medal of Excellence Awards honor six undergraduate scholars for scholarship, leadership, character, service and the ideals of the university. Awardees are spotlighted for exceptional academics, creativity, community service and innovation.

2

Grad students earn president's highest honor

April 28, 2021

The University of Cincinnati 2021 Presidential Medal of Graduate Student Excellence Awards honor three graduate scholars for scholarship, leadership, character, service and the ideals of the university. Awardees are spotlighted for exceptional academics, creativity, community service and innovation.

3

Finding community and building a future

July 9, 2021

As a University of Cincinnati College of Medicine student, Sarah Appeadu, MD, ’21, remembers journaling on the “3 Cs” that got her through medical school: Community, community, community. Now, when she lists the people who supported her through four years of training—the last year in a global pandemic—it keeps growing: her family, her church, her classmates, and the college’s Office of Student Affairs and Office of Diversity, Equity and Inclusion. “I look back and it was such a crucial time to really be nurtured in that way,” she says. “I’m so thankful that I had those people. It shows being around the right people really mattered. That’s my same hope for residency even.”

7

UC Receives $1.9 Million to Study Pain

February 15, 2016

Jun-Ming Zhang, MD, of the UC College of Medicine, is the principal investigator of a $1.95 million grant to study the interacting roles of the sympathetic and sensory nervous and immune systems in back and neuropathic pain models.

8

MD Magazine: Generic Drug Equally Effective in Epilespy

February 22, 2016

Michael Privitera, MD, a professor of neurology at UC's College of Medicine and director of the Epilepsy Center at the UC Neuroscience Institute, is featured in this story about research he led that examined the efficacy of generic drug substitution for epilepsy.